Log in to save to my catalogue

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fb1fbb0de664cbdac06f9837a479b3c

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment

About this item

Full title

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2020-02, Vol.11 (1), p.1137-16, Article 1137

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The interaction between immune cells and phosphatidylserine (PS) molecules exposed on the surface of apoptotic-tumor bodies, such as those induced by chemotherapies, contributes to the formation of an immunosuppressive tumor microenvironment (TME). Annexin A5 (AnxA5) binds with high affinity to PS externalized by apoptotic cells, thereby hindering...

Alternative Titles

Full title

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2fb1fbb0de664cbdac06f9837a479b3c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fb1fbb0de664cbdac06f9837a479b3c

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-14821-z

How to access this item